PCV49 COST-EFFECTIVENESS OF ALIROCUMAB FOR PATIENTS WITH HYPERCHOLESTEROLEMIA AT HIGH CV RISK
May 1, 2019, 00:00 AM
10.1016/j.jval.2019.04.485
https://www.valueinhealthjournal.com/article/S1098-3015(19)30677-1/fulltext
Section Title :
Section Order :
10127
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)30677-1&doi=10.1016/j.jval.2019.04.485